Comparison of Epidemiology, Clinical Features, and Outcomes of Patients with Reported Ewing Sarcoma and PNET over 40 Years Justifies Current WHO Classification and Treatment Approaches
Open Access
Abstract
Background. As of 2013, the WHO has classified peripheral primitive neuroectodermal tumors (PNETs) within the umbrella of Ewing sarcoma family of tumors (ESFTs) given their shared biology. Histologic features differ between PNET and Ewing sarcoma (ES), and potential clinical differences between PNET and ES have not been fully elucidated. Methods. Through the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) database, we identified 3,575 patients identified with histologic diagnosis of ES or PNET from 1973 to 2014. We used Fisher's exact tests to compare patient and tumor characteristics between groups. Kaplan–Meier methods were used to estimate overall survival. Results. Patients with ES were more likely to be male, ≤18 years old at diagnosis, white, and hispanic compared to patients with PNET ( for sex; for all other variables). Patients with PNET were more likely to have soft tissue primary tumors (), and among those with bone tumors, a lower rate of axial or pelvic tumors (). Patients with PNET had significantly worse 5-year survival compared to ES patients, though the absolute difference was small (51.3% versus 55.5%; ). Survival of patients with PNET diagnosed in the 1990s or later more closely approximated patients with ES, while patients with PNET diagnosed in the 1980's and earlier had inferior outcomes. Conclusions. Despite shared underlying biology, patients with PNET and ES show differences in clinical presentation and overall survival, with the latter differences largely mitigated in more recent decades.
Keywords
This publication has 18 references indexed in Scilit:
- Identification of Discrete Prognostic Groups in Ewing SarcomaPediatric Blood & Cancer, 2015
- Superficial EWSR1-negative undifferentiated small round cell sarcoma with CIC/DUX4 gene fusion: a new variant of Ewing-like tumors with locoregional lymph node metastasisVirchows Archiv, 2013
- Randomized Controlled Trial of Interval-Compressed Chemotherapy for the Treatment of Localized Ewing Sarcoma: A Report From the Children's Oncology GroupJournal of Clinical Oncology, 2012
- A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusionNature Genetics, 2012
- Clinical features and outcomes in patients with extraskeletal ewing sarcomaCancer, 2011
- Analysis of prognostic factors in ewing sarcoma family of tumorsCancer, 2007
- Addition of Ifosfamide and Etoposide to Standard Chemotherapy for Ewing's Sarcoma and Primitive Neuroectodermal Tumor of BoneNew England Journal of Medicine, 2003
- The Ewing Family of Tumors -- A Subgroup of Small-Round-Cell Tumors Defined by Specific Chimeric TranscriptsNew England Journal of Medicine, 1994
- Comparison of Cell Surface Antigen HBA71 (p30/32MIC2), Neuron-Specific Enolase, and Vimentin in the Immunohistochemical Analysis of Ewingʼs Sarcoma of BoneAmerican Journal of Surgical Pathology, 1992
- Ewing's sarcomaVirchows Archiv, 1989